drugset / Trial / NCT02997722

The Effect of Ketamine on the Length of Hospital Stay of Patients Hospitalized With Suicidal Ideation.

NCT02997722 ↗

Phase 4 Terminated 4 enrolled Allen Richert
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the effect of ketamine on the treatment of patients hospitalized with suicidal thoughts. Half of the patients will receive one dose of ketamine in the vein. The other half will receive a placebo. Because we think that ketamine will improve depression and suicidal thoughts, we expect that patients who receive ketamine will require less time in the hospital than patients who receive placebo.

Timeline

Start
2017-03-02
Primary completion
2017-05-19
Completion
2017-05-19

Outcome

Outcome not reported

Stopped: “Staffing and space deficiencies prevented completion of the study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous

Indications

No indication recorded.